JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$17.26
-0.21 (-1.20%)
Open$17.34
Previous Close$17.47
Day High$17.48
Day Low$17.12
52W High$35.34
52W Low$12.12
Volume—
Avg Volume964.7K
Market Cap1.01B
P/E Ratio—
EPS$-1.64
SectorBiotechnology
Analyst Ratings
Strong Buy
26 analysts
Price Target
+184.5% upside
Current
$17.26
$17.26
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.76M | 9.29M | 135.69M |
| Net Income | -110,895,733 | -94,944,976 | 14.63M |
| Profit Margin | -1,136.3% | -1,079.4% | 10.8% |
| EBITDA | -151,901,028 | -137,277,375 | 20.57M |
| Free Cash Flow | — | — | 20.68M |
| Rev Growth | +5.1% | +5.1% | +1.9% |
| Debt/Equity | — | — | 0.42 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |